Get the Stockscreener App
12.61
8.22%
-1.13
After Hours:
12.86
0.25
+1.98%
Arcturus Therapeutics Holdings Inc Stock (ARCT) Forecast
The Arcturus Therapeutics Holdings Inc (ARCT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $8.0425, representing a -36.22% decrease from the current price of $12.61. The highest analyst price target is $14.94, and the lowest is $1.1429.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARCT Price Target
Average 8.6337
(-31.53% Downside)
Is Arcturus Therapeutics Holdings Inc (ARCT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.92 | Neutral |
| STOCH(9,6) | 33.14 | Neutral |
| STOCHRSI(14) | 56.82 | Neutral |
| MACD(12,26) | -0.1035 | Sell |
| ADX(14) | 21.80 | Neutral |
| William %R | -81.53 | Buy |
| CCI(14) | -42.97 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
13.33
Sell
|
13.38
Sell
|
| MA20 |
14.12
Sell
|
13.65
Sell
|
| MA50 |
12.68
Sell
|
12.62
Sell
|
| MA100 |
9.7763
Buy
|
11.03
Buy
|
| MA200 |
8.6981
Buy
|
10.59
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, ARCT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ARCT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.92 indicates that ARCT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.14 indicates that ARCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 56.82 indicates that ARCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.8 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -42.97 indicates that ARCT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ARCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arcturus Therapeutics Holdings Inc financial reports and earnings history, Arcturus Therapeutics Holdings Inc (ARCT) stock could reach $3.1526 by 2030, $48.30 by 2040 and $126.09 by 2050. See the projected annual prices until 2050 of the Arcturus Therapeutics Holdings Inc stock below:
- Arcturus Therapeutics Holdings Inc (ARCT) is expected to reach an average price of $11.11 in 2035, with a high prediction of $11.04 and a low estimate of $12.74. This indicates an $-11.87% rise from the last recorded price of $12.61.
- Arcturus Therapeutics Holdings Inc (ARCT) stock is projected to chart a bullish course in 2040, with an average price target of $45.92, representing an $264.16% surge from its current level. The forecast ranges from a conservative $48.80 to a sky-high $48.30.
- Our analysts predict Arcturus Therapeutics Holdings Inc (ARCT) to jump 647.73% by 2045, soaring from $93.70 to an average price of $94.29, potentially reaching $94.11. While $93.70 is the low estimate, the potential upside is significant.
- Arcturus Therapeutics Holdings Inc (ARCT) stock is expected to climb by 2050, reaching an average of $131.33, a $941.46% jump from its current level. However, a wide range of estimates exists, with high and low targets of $126.09 and $126.64, respectively, highlighting the market's uncertainty.
Arcturus Therapeutics Holdings Inc Stock (ARCT) Year by Year Forecast
Arcturus Therapeutics Holdings Inc Stock (ARCT) Price Forecast for 2026
The predicted value for Arcturus Therapeutics Holdings Inc (ARCT) in 2026 is set at an average of $9.4786. Estimates vary from a peak of $17.96 to a trough of $0.9973, indicating an -24.83% surge from the present price of $12.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $7.3544 | $1.1429 | $14.94 | -41.68% |
| December, 2026 | $14.83 | $0.9973 | $15.40 | +17.58% |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arcturus Therapeutics Holdings Inc (ARCT) is $8.6337, with a high forecast of $16.62 and a low forecast of $0.6494. This indicates an -31.53% decrease from the last price of $12.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.5902 | $0.6494 | $16.62 | -87.39% |
| February, 2027 | $7.2969 | $7.2391 | $5.5077 | -42.13% |
| March, 2027 | $12.31 | $7.9462 | $7.6433 | -2.35% |
| April, 2027 | $3.8804 | $4.2604 | $11.08 | -69.23% |
| May, 2027 | $11.06 | $3.5997 | $8.1568 | -12.32% |
| June, 2027 | $9.2339 | $12.11 | $11.75 | -26.77% |
| July, 2027 | $16.32 | $10.91 | $15.47 | +29.43% |
| August, 2027 | $12.64 | $13.12 | $13.19 | +0.22% |
| September, 2027 | $9.8844 | $12.06 | $11.61 | -21.61% |
| October, 2027 | $14.42 | $12.53 | $13.25 | +14.37% |
| November, 2027 | $12.95 | $13.88 | $12.95 | +2.68% |
| December, 2027 | $10.32 | $11.19 | $12.16 | -18.20% |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Price Forecast for 2028
In 2028, Arcturus Therapeutics Holdings Inc (ARCT) is projected to reach an average price of $6.6822, with a high projection of $13.13 and a low estimate of $0.239. This indicates an -47.01% fall from the last price of $12.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.1714 | $10.14 | $10.91 | -27.27% |
| February, 2028 | $10.04 | $9.9407 | $8.3307 | -20.39% |
| March, 2028 | $8.1456 | $8.8256 | $9.432 | -35.40% |
| April, 2028 | $7.5027 | $5.8834 | $5.6741 | -40.50% |
| May, 2028 | $11.50 | $8.9219 | $10.00 | -8.81% |
| June, 2028 | $0.2039 | $2.3561 | $10.14 | -98.38% |
| July, 2028 | $5.0675 | $0.239 | $8.2875 | -59.81% |
| August, 2028 | $1.6904 | $0.3865 | $6.1782 | -86.59% |
| September, 2028 | $3.8133 | $1.0018 | $5.0133 | -69.76% |
| October, 2028 | $10.50 | $2.814 | $13.13 | -16.76% |
| November, 2028 | $7.2798 | $0.7584 | $11.61 | -42.27% |
| December, 2028 | $4.7227 | $4.1827 | $9.232 | -62.55% |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Price Forecast for 2029
The 2029 price forecast for Arcturus Therapeutics Holdings Inc Stock (ARCT) is $12.33 on average, with a high prediction of $24.65 and a low estimate of $0.0137. This represents an -2.19% decrease from the previous price of $12.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.2336 | $0.7749 | $5.3835 | -74.36% |
| February, 2029 | $3.9307 | $4.8807 | $3.7422 | -68.83% |
| March, 2029 | $2.1022 | $0.0493 | $3.7807 | -83.33% |
| April, 2029 | $8.8658 | $0.0137 | $11.76 | -29.69% |
| May, 2029 | $10.93 | $8.1065 | $12.86 | -13.33% |
| June, 2029 | $15.70 | $10.37 | $19.88 | +24.52% |
| July, 2029 | $12.59 | $11.21 | $22.17 | -0.20% |
| August, 2029 | $4.9881 | $4.5781 | $14.44 | -60.44% |
| September, 2029 | $6.591 | $4.4989 | $8.411 | -47.73% |
| October, 2029 | $10.73 | $7.1718 | $24.65 | -14.87% |
| November, 2029 | $3.2176 | $0.4969 | $10.20 | -74.48% |
| December, 2029 | $1.4588 | $0.4325 | $5.6783 | -88.43% |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Price Forecast for 2030
Arcturus Therapeutics Holdings Inc Stock (ARCT) is expected to reach an average price of $3.5588 in 2030, with a high forecast of $7.0677 and a low forecast of $0.0499. This signifies an -71.78% decrease from the last price of $12.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.5259 | $0.6533 | $3.1526 | -95.83% |
| February, 2030 | $4.317 | $0.5852 | $4.657 | -65.77% |
| March, 2030 | $0.3799 | $0.0499 | $7.0677 | -96.99% |
| April, 2030 | $1.2565 | $0.8294 | $3.3628 | -90.04% |
| May, 2030 | $2.3636 | $1.065 | $2.915 | -81.26% |
| June, 2030 | $0.4593 | $0.1457 | $3.7393 | -96.36% |
| July, 2030 | $0.933 | $1.2485 | $1.768 | -92.60% |
| August, 2030 | $2.7141 | $0.4963 | $2.2137 | -78.48% |
| September, 2030 | $6.6905 | $5.1134 | $6.0105 | -46.94% |
| October, 2030 | $3.2376 | $3.8983 | $5.3098 | -74.33% |
| November, 2030 | $3.2147 | $4.2347 | $3.2069 | -74.51% |
| December, 2030 | $2.3311 | $2.3711 | $2.0825 | -81.51% |
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):